ATE334215T1 - Verwendung des aminoglycosidresistenzgens - Google Patents

Verwendung des aminoglycosidresistenzgens

Info

Publication number
ATE334215T1
ATE334215T1 AT02799440T AT02799440T ATE334215T1 AT E334215 T1 ATE334215 T1 AT E334215T1 AT 02799440 T AT02799440 T AT 02799440T AT 02799440 T AT02799440 T AT 02799440T AT E334215 T1 ATE334215 T1 AT E334215T1
Authority
AT
Austria
Prior art keywords
resistance gene
aminoglycoside resistance
aminoglycoside
gene product
animal cells
Prior art date
Application number
AT02799440T
Other languages
English (en)
Inventor
Mohamed Al-Rubeai
Angelo Perani
Andy Racher
John Birch
Original Assignee
Lonza Biologics Plc
Mohamed Al-Rubeai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Biologics Plc, Mohamed Al-Rubeai filed Critical Lonza Biologics Plc
Application granted granted Critical
Publication of ATE334215T1 publication Critical patent/ATE334215T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/38Vector systems having a special element relevant for transcription being a stuffer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
AT02799440T 2001-09-26 2002-09-26 Verwendung des aminoglycosidresistenzgens ATE334215T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0123098.6A GB0123098D0 (en) 2001-09-26 2001-09-26 Use of aminoglycoside resistance gene
US38759502P 2002-06-16 2002-06-16
PCT/GB2002/004522 WO2003027300A2 (en) 2001-09-26 2002-09-26 Use of aminoglycoside resistance gene

Publications (1)

Publication Number Publication Date
ATE334215T1 true ATE334215T1 (de) 2006-08-15

Family

ID=26246578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799440T ATE334215T1 (de) 2001-09-26 2002-09-26 Verwendung des aminoglycosidresistenzgens

Country Status (13)

Country Link
US (1) US7439037B2 (de)
EP (1) EP1438411B1 (de)
JP (1) JP4267450B2 (de)
KR (1) KR100982153B1 (de)
CN (1) CN100402653C (de)
AT (1) ATE334215T1 (de)
AU (1) AU2002334102A1 (de)
DE (1) DE60213441T2 (de)
DK (1) DK1438411T3 (de)
ES (1) ES2269807T3 (de)
GB (1) GB0123098D0 (de)
NO (1) NO332092B1 (de)
WO (1) WO2003027300A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2343362T3 (pl) * 2006-07-14 2016-11-30 Udoskonalony sposób hodowania komórek
CN113981027A (zh) * 2015-04-27 2022-01-28 动量制药公司 制备治疗性蛋白质的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024947A (en) 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5077214A (en) * 1989-07-07 1991-12-31 The Texas A&M University System Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
WO1994026087A2 (en) * 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
FR2708284B1 (fr) * 1993-07-26 1995-10-20 Agronomique Inst Nat Rech Séquences nucléotidiques permettant la réplication et le maintien d'une information génétique dans les cellules animales.
GB2289946B (en) 1994-05-26 1998-09-23 Food Industry Res & Dev Inst Method
KR20010069066A (ko) * 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법

Also Published As

Publication number Publication date
KR20040054698A (ko) 2004-06-25
WO2003027300A3 (en) 2003-08-21
US20050112722A1 (en) 2005-05-26
DE60213441T2 (de) 2007-12-13
NO20041856D0 (no) 2004-04-23
NO332092B1 (no) 2012-06-18
CN1705749A (zh) 2005-12-07
DK1438411T3 (da) 2006-11-20
JP2005518189A (ja) 2005-06-23
CN100402653C (zh) 2008-07-16
GB0123098D0 (en) 2001-11-14
EP1438411B1 (de) 2006-07-26
KR100982153B1 (ko) 2010-09-14
NO20041856L (no) 2004-06-22
EP1438411A2 (de) 2004-07-21
ES2269807T3 (es) 2007-04-01
JP4267450B2 (ja) 2009-05-27
AU2002334102A1 (en) 2003-04-07
DE60213441D1 (de) 2006-09-07
US7439037B2 (en) 2008-10-21
WO2003027300A2 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
SI1520008T1 (sl) Mediji brez Ĺľivalskih proteinov za kultiviranje celic
HK1079547A1 (en) Cell growth inhibitors containing anti-glypican 3 antibody
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
WO2005028443A3 (en) Protein tyrosine kinase enzyme inhibitors
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
DE60035032D1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
TR200003170T2 (tr) MRS inhibitörleri ve bakterisid olarak kullanılan quinolone'lar
ATE256677T1 (de) Inhibitoren der bakteriellen nad synthetase
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
BRPI0411837A (pt) pirazolopirimidinas
MXPA02002838A (es) Derivados de piperazina sustituidos, su obtencion y uso como medicamentos.
ATE334215T1 (de) Verwendung des aminoglycosidresistenzgens
TR199901386T2 (en) �midazopiridazinler.
AU2003223634A1 (en) Peptide deformylase inhibitors
GB0103240D0 (en) Organic compounds
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
EP1476149A4 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
DE50308032D1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
AU2002258437A1 (en) Peptide deformylase inhibitors
AU2002322035A1 (en) Peptide deformylase inhibitors
DE60232650D1 (de) Peptiddeformylaseinhibitoren
ZA200110213B (en) The use of the protein UK 114 for inhibiting organ transplant rejection.
AU2002255635A1 (en) Peptide deformylase inhibitors
TW200505413A (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1438411

Country of ref document: EP